Biologicals in psoriasis

Vandana Mehta; C. Balachandran

Biologicals in psoriasis

Vandana Mehta^*
, C. Balachandran

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

5 Citations (Scopus)

Abstract

During the recent years, a new class of therapeutic agents has been introduced for the treatment of psoriasis and psoriatic arthritis. These agents target different inflammatory mediators involved in the pathogenesis of disease. The focus of this article is on the mechanism of action, side effect profile and dosing of the agents currently in use today for the treatment of psoriasis.

Original language	English
Pages (from-to)	100-109
Number of pages	10
Journal	Journal of Pakistan Association of Dermatologists
Volume	18
Issue number	2
Publication status	Published - 01-04-2008
Externally published	Yes

All Science Journal Classification (ASJC) codes

Dermatology

Cite this

@article{b18009fbe3e54c4e9c4b8c65682cb8a1,

title = "Biologicals in psoriasis",

abstract = "During the recent years, a new class of therapeutic agents has been introduced for the treatment of psoriasis and psoriatic arthritis. These agents target different inflammatory mediators involved in the pathogenesis of disease. The focus of this article is on the mechanism of action, side effect profile and dosing of the agents currently in use today for the treatment of psoriasis.",

author = "Vandana Mehta and C. Balachandran",

year = "2008",

month = apr,

day = "1",

language = "English",

volume = "18",

pages = "100--109",

journal = "Journal of Pakistan Association of Dermatologists",

issn = "1560-9014",

publisher = "Pakistan Association of Dermatologists",

number = "2",

}

TY - JOUR

T1 - Biologicals in psoriasis

AU - Mehta, Vandana

AU - Balachandran, C.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - During the recent years, a new class of therapeutic agents has been introduced for the treatment of psoriasis and psoriatic arthritis. These agents target different inflammatory mediators involved in the pathogenesis of disease. The focus of this article is on the mechanism of action, side effect profile and dosing of the agents currently in use today for the treatment of psoriasis.

AB - During the recent years, a new class of therapeutic agents has been introduced for the treatment of psoriasis and psoriatic arthritis. These agents target different inflammatory mediators involved in the pathogenesis of disease. The focus of this article is on the mechanism of action, side effect profile and dosing of the agents currently in use today for the treatment of psoriasis.

UR - https://www.scopus.com/pages/publications/50249184691

UR - https://www.scopus.com/pages/publications/50249184691#tab=citedBy

M3 - Review article

AN - SCOPUS:50249184691

SN - 1560-9014

VL - 18

SP - 100

EP - 109

JO - Journal of Pakistan Association of Dermatologists

JF - Journal of Pakistan Association of Dermatologists

IS - 2

ER -

Biologicals in psoriasis

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this